Mirtazapine for Methamphetamine Use Disorder

Addiction Journal Club - Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial

Addiction Journal Club (AJC) is a monthly session where we meet to review an evidence-based, open-access article and discuss its implications for substance use disorder (SUD) practice. This includes new research and landmark studies relevant to SUD practice. AJC is distinct from other BMC Grayken Center for Addiction TTA events; it is designed to be less didactic and more of an interactive review of emerging data and trends related to caring for persons who use substances. It is also a great opportunity to network with addiction colleagues and share experiences about clinical practices.

This month, we will be joined by Steven Shoptaw, PhD, one of the co-authors of the article, to review and discuss "Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial" by McKetin R, Shoptaw S, Saunders L, et al. Click here to read the open-access article.

Learn more and register

For trainings that indicate Continuing Education Units (CEUs) are available, contact your licensing or certification organization to verify that the credits will count toward the continuing education requirements.